Matthew Signal - Concepedia

Concepedia

Author

Matthew Signal

University of Canterbury

Also Known As

M Signal, M. Signal, Matthew K Signal, Matthew K. Signal, Matthew SIGNAL, Matthew Signal, Signal, Matthew Kent

50

Publications

1.3K

Citations

16

H-Index

40

Concepts

All Affiliations

University of Canterbury University of Auckland Christchurch Hospital University of Otago Waikato District Health Board

MS

About

Matthew Signal is an author at University of Canterbury specializing in medicine, diabetes, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	519
2	Health Sciences	2	2	35
3	Education	1	1	21
4	Engineering	1	1	17
5	Athletic Training	1	1	14

Matthew Signal

×

18

Publications

1.3K

Citations

16

H-Index

	Year	Citations
Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years Christopher J. D. McKinlay, Jane M. Alsweiler, J. Ansell, New England Journal of Medicine	2015	359
Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial Deborah L. Harris, Philip J. Weston, Matthew Signal, The Lancet NeonatologyDiabetesInfant NutritionPediatricsDextrose Gel	2013	293
Outcome at 2 Years after Dextrose Gel Treatment for Neonatal Hypoglycemia: Follow-Up of a Randomized Trial Deborah L. Harris, Jane M. Alsweiler, J. Ansell, The Journal of Pediatrics NeonatologyPediatricsNewborn MedicineRandomized TrialMedicine	2015	110
Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control Alicia Evans, Geoffrey M. Shaw, Aaron Le Compte, Annals of Intensive Care	2011	90
Glycemic Levels in Critically Ill Patients: Are Normoglycemia and Low Variability Associated with Improved Outcomes? Matthew Signal, Aaron Le Compte, G. M. Shaw, Journal of Diabetes Science and Technology	2012	66
Does the achievement of an intermediate glycemic target reduce organ failure and mortality? A post hoc analysis of the Glucontrol trial Sophie Penning, J. Geoffrey Chase, Jean‐Charles Preiser, Journal of Critical Care ObesityMetabolic SyndromeDiabetes ManagementDiabetesIntermediate Glycemic Target	2014	40
Continuous Glucose Monitors and the Burden of Tight Glycemic Control in Critical Care: Can They Cure the Time Cost? Matthew Signal, Christopher G. Pretty, J. Geoffrey Chase, Journal of Diabetes Science and Technology	2010	40
Cost Analysis of Treating Neonatal Hypoglycemia with Dextrose Gel Matthew J. Glasgow, Jane E. Harding, Richard Edlin, The Journal of Pediatrics NeonatologyInfant NutritionPediatricsCost AnalysisMedicine	2018	38
Impact of Retrospective Calibration Algorithms on Hypoglycemia Detection in Newborn Infants Using Continuous Glucose Monitoring Matthew Signal, Aaron Le Compte, Deborah L. Harris, Diabetes Technology & Therapeutics	2012	36
Mechanical behaviour of tissue mimicking breast phantom materials Hina Ismail, Christopher G. Pretty, Matthew Signal, Biomedical Physics & Engineering Express	2017	34

Page 1